Financing, Licensing & M&A 4Q16

20 January 2017

This report, published every quarter, includes analytics on Financing, IPOs, Licensing and M&A deals based on BioPharm Insight’s data. It also highlights a selection of BPI’s editorial coverage on such activity based on interviews with C-level executives as well as trends based on conversations with industry experts.

Companies mentioned in this report: Actelion, AFT Pharmaceutical, AntibioTx, Bill and Melinda Gates Foundation, Biogen, China Resources Pharmaceutical, Critical Pharmaceuticals, Eli Lilly, Galapagos, GeneQuine, Gradalis, InMed, Innovent Biologics, Intarcia Therapeutics, Ionis Pharmaceuticals, Ipsen, Medherant, Myovant Sciences, OncoSec, Palatin Technologies, PDL BioPharma, Samsung BioLogics, Sermonix, and Viracta